What is he best known for?
The fields of study he is best known for:
- Gene
- Immune system
- Internal medicine
T cell, T-cell receptor, Molecular biology, Antigen and Cell biology are his primary areas of study.
His T cell research is multidisciplinary, relying on both Cytotoxic T cell, T lymphocyte and CD8.
The study incorporates disciplines such as Flow cytometry and Immunology in addition to Cytotoxic T cell.
His work deals with themes such as Receptor, Peptide sequence and Major histocompatibility complex, which intersect with T-cell receptor.
His Molecular biology research includes themes of Complementary DNA, Gene rearrangement, Gene, Gene expression and DNA.
His study in Cell biology is interdisciplinary in nature, drawing from both Immunological synapse, Cytoskeleton and Immunological synapse formation.
His most cited work include:
- Phenotypic Analysis of Antigen-Specific T Lymphocytes (3448 citations)
- The Immunological Synapse: A Molecular Machine Controlling T Cell Activation (2682 citations)
- T-cell antigen receptor genes and T-cell recognition. (2501 citations)
What are the main themes of his work throughout his whole career to date?
Mark M. Davis mainly investigates Immunology, T cell, T-cell receptor, Molecular biology and Antigen.
His Immunology study frequently links to related topics such as Virology.
His T cell research includes elements of Cytotoxic T cell, CD8 and Cell biology.
Mark M. Davis focuses mostly in the field of T-cell receptor, narrowing it down to topics relating to Major histocompatibility complex and, in certain cases, Peptide and Antigen presentation.
His Molecular biology research integrates issues from Complementary DNA and Gene.
Mark M. Davis studies Antigen, focusing on Epitope in particular.
He most often published in these fields:
- Immunology (39.01%)
- T cell (33.76%)
- T-cell receptor (33.19%)
What were the highlights of his more recent work (between 2017-2021)?
- Immune system (26.67%)
- Immunology (39.01%)
- Antigen (27.94%)
In recent papers he was focusing on the following fields of study:
Mark M. Davis spends much of his time researching Immune system, Immunology, Antigen, T cell and Cancer research.
His work carried out in the field of Immune system brings together such families of science as Germinal center, Computational biology and Influenza vaccine.
His research integrates issues of RNA, Antigen presentation and Vaccination in his study of Antigen.
Mark M. Davis is interested in T-cell receptor, which is a field of T cell.
The concepts of his T-cell receptor study are interwoven with issues in Epitope, Receptor, Pancreatic disease and Molecular biology.
His Cancer research research incorporates elements of Cancer, Immunotherapy and Induced pluripotent stem cell.
Between 2017 and 2021, his most popular works were:
- Organoid Modeling of the Tumor Immune Microenvironment. (302 citations)
- Organoid Modeling of the Tumor Immune Microenvironment. (302 citations)
- Clonal replacement of tumor-specific T cells following PD-1 blockade. (290 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Immune system
- Internal medicine
His primary areas of investigation include Immune system, Immunology, Antigen, T cell and Cell biology.
The Immune system study combines topics in areas such as Young adult, Cell, Cancer research and Disease.
His research in Antigen intersects with topics in Gene, Antigen presentation and T-cell receptor.
Mark M. Davis has included themes like Acquired immune system, Glycosylation, CD8, Major histocompatibility complex and Cohort in his T cell study.
His studies deal with areas such as Jurkat cells, Experimental autoimmune encephalomyelitis, Central nervous system, Molecular biology and Peptide as well as Major histocompatibility complex.
Mark M. Davis interconnects Glycoproteomics, Proteomics, Glycoprotein and Transcription factor in the investigation of issues within Cell biology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
